Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed

Hepatology

Volumn 34, Issue 5, 2001, Pages 1012-1020

  Lewin, Sharon R ^a,b   Ribeiro, Ruy M ^c   Walters, Tomos ^a   Lau, George K ^d   Bowden, Scott ^a   Locarnini, Stephen ^a   Perelson, Alan S ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG POTENCY; FEMALE; FOLLOW UP; HALF LIFE TIME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; VIRUS LOAD;

EID: 0034756599     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28509     Document Type: Article

References (37)

1. Viral dynamics in human immunodeficiency virus type 1 infection
2. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
3. Decay characteristics of HIV-1-infected compartments during combination therapy
4. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
5. Viral dynamics in hepatitis B virus infection
6. Dynamics of hepatitis B virus infection in vivo
7. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy
8. Quantitative image analysis of HIV-1 infection in lymphoid tissue
9. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
10. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
11. Lamivudine as initial treatment for chronic hepatitis B in the United States
12. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
13. Famciclovir in chronic hepatitis B: Results of a dose-finding study
14. A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection
15. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study
16. Molecular beacons: Probes that fluoresce upon hybridization
17. The use of real-time PCR and molecular beacons to detect virusreplication in HIV-1-infected individuals on prolonged effective antiretroviral therapy
18. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy
19. Hepatitis C virus particle detected by immunoelectron microscopic study
20. Entry, dissemination, shedding, and transmission of viruses
21. Real-time quantitative RT-PCR after laser-assisted cell picking
22. A novel method for real time quantitative RT-PCR
23. Real time quantitative PCR
24. Line probe assay for monitoring drug resistance in hepatitis B virus infected patients during antiviral therapy
25. Viral clearance without destruction of infected cells during acute HBV infection
26. Analysis of the earliest steps of hepadnavirus replication: Genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity
27. Structure and molecular virology
28. Use of hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-β-2′, 3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA
29. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system
30. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays
31. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-β, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)
32. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
33. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
34. Lamivudine treatment can restore T-cell responsiveness in chronic hepatitis B
35. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
36. Cellular factors for resistance against antiretroviral agents
37. Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy